Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VRTX | GILD | BMY | ||
| Company | Vertex Pharmaceutic | Gilead Sciences Inc | Bristol-Myers Squibb Company | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 526.66 | 132.88 | 57.74 | ||
| High | 529.99 | 132.88 | 58.11 | ||
| Low | 512.34 | 127.88 | 56.49 | ||
| Latest | 529.59 | 129.61 | 56.70 | ||
| Change | +1.55 | -1.66 | -1.43 | ||
| % Change | +0.29% | -1.26% | -2.46% | ||
| Volume | 1,515,700 | 10,729,300 | 9,313,000 | ||
| 20-Day Average Volume | 1,895,630 | 9,346,585 | 13,333,646 | ||
| Previous Close | 528.04 | 131.27 | 58.13 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 470.47 | 126.14 | 56.30 | ||
| 20-Day Raw Stochastic | 99.58% | 71.54% | 59.93% | ||
| 20-Day Relative Strength | 75.64 | 51.08 | 49.76 | ||
| Weighted Alpha | +24.38 | +12.99 | +18.51 | ||
| Today's Opinion | 72% Buy | 56% Sell | 16% Sell | ||
| Previous Opinion | 72% Buy | 40% Sell | 32% Buy | ||
| Last Month's Opinion | 48% Sell | 24% Sell | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +7.78% since 06/26/26 | +1.35% since 06/26/26 | -1.43% since 06/26/26 | ||
| Low | 487.62 on 06/29/26 | 124.19 on 06/30/26 | 56.30 on 07/01/26 | ||
| High | 529.99 on 07/06/26 | 132.88 on 07/06/26 | 58.88 on 06/30/26 | ||
| 1-Month | |||||
| %Chg | +18.52% since 06/05/26 | +0.35% since 06/05/26 | -1.00% since 06/05/26 | ||
| Low | 433.80 on 06/10/26 | 121.39 on 06/10/26 | 53.44 on 06/18/26 | ||
| High | 529.99 on 07/06/26 | 132.88 on 07/06/26 | 58.88 on 06/30/26 | ||
| 3-Month | |||||
| %Chg | +21.94% since 04/06/26 | -7.51% since 04/06/26 | -4.43% since 04/06/26 | ||
| Low | 412.27 on 05/05/26 | 121.39 on 06/10/26 | 53.44 on 06/18/26 | ||
| High | 529.99 on 07/06/26 | 142.97 on 04/09/26 | 60.78 on 04/30/26 | ||
| 6-Month | |||||
| %Chg | +13.07% since 01/06/26 | +6.80% since 01/06/26 | +4.19% since 01/06/26 | ||
| Low | 412.27 on 05/05/26 | 119.33 on 01/09/26 | 53.44 on 06/18/26 | ||
| High | 529.99 on 07/06/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 134,019,184 | 162,980,896 | 118,705,592 | ||
| Shares Outstanding, K | 253,805 | 1,241,570 | 2,042,071 | ||
| Annual Sales | 12,001,300,000 | 29,443,000,000 | 48,194,000,000 | ||
| Annual Net Income | 3,953,200,000 | 8,510,000,000 | 7,054,000,000 | ||
| Last Quarter Sales | 2,986,900,000 | 6,960,000,000 | 11,489,000,000 | ||
| Last Quarter Net Income | 1,031,400,000 | 2,021,000,000 | 2,677,000,000 | ||
| 60-Month Beta | 0.29 | 0.32 | 0.23 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 4.47 on 05/04/26 | 2.03 on 05/07/26 | 1.58 on 04/30/26 | ||
| Earnings Date | 08/03/26 | 08/06/26 | 07/30/26 | ||
| Most Recent Dividend | N/A | 0.820 on 06/15/26 | 0.630 on 07/02/26 | ||
| Next Ex-Dividends Date | N/A | 06/15/26 | 07/02/26 | ||
| Ratios | |||||
| Price/Earnings ttm | 29.61 | 15.05 | 9.52 | ||